Corporate Profile
MediWound is the global leader in next-generation enzymatic therapeutics focused on non-surgical tissue repair. Specializing in the development, production and commercialization of solutions that seek to replace existing standards of care, we are committed to providing rapid and effective biologics that improve patient experiences and outcomes, while reducing costs and unnecessary surgeries.
Change
Volume
52 Week High
52 Week Low
Data Provided by Refinitiv. Minimum 15 minutes delayed.
